Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, et al. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019;50(3):e51–96.

Article  PubMed  Google Scholar 

Bhattacharya P, Sarmah D, Dave KR, Goswami A, Watanabe M, Wang X, et al. Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries. J Neurol Sci. 2021;427: 117510.

Article  PubMed  Google Scholar 

Hirtz D, Kirkham FJ. Sickle Cell Disease and Stroke. Pediatr Neurol. 2019;95:34–41.

Article  PubMed  Google Scholar 

Mack AK, Thompson AA. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease. J Pediatr Health Care. 2017;31(2):145–54.

Article  PubMed  Google Scholar 

Jordan LC, Casella JF, DeBaun MR. Prospects for primary stroke prevention in children with sickle cell anaemia. Br J Haematol. 2012;157(1):14–25.

Article  CAS  PubMed  Google Scholar 

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010.

Article  PubMed  Google Scholar 

Prevention CfDCa. [cited 2023 July 6, 2023]. Available from: https://www.cdc.gov/ncbddd/sicklecell/data.html.

Grosse SD, Schechter MS, Kulkarni R, Lloyd-Puryear MA, Strickland B, Trevathan E. Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics. 2009;123(1):407–12.

Article  PubMed  Google Scholar 

Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61(2):189–94.

Article  PubMed  Google Scholar 

Bernaudin F, Verlhac S, Coic L, Lesprit E, Brugieres P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol. 2005;35(3):242–8.

Article  PubMed  Google Scholar 

Debaun MR, Derdeyn CP, McKinstry RC 3rd. Etiology of strokes in children with sickle cell anemia. Ment Retard Dev Disabil Res Rev. 2006;12(3):192–9.

Article  PubMed  Google Scholar 

Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.

Article  CAS  PubMed  Google Scholar 

Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605–10.

Article  CAS  PubMed  Google Scholar 

Adams RJ, Brambilla D, Optimizing Primary Stroke Prevention in Sickle Cell Anemia Trial I. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769–78.

Article  CAS  PubMed  Google Scholar 

Ware RE, Helms RW, Investigators SW. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). Blood. 2012;119(17):3925–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016;387(10019):661–70.

Article  CAS  PubMed  Google Scholar 

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):699–710.

Article  PubMed  PubMed Central  Google Scholar 

Kwiatkowski JL, Voeks JH, Kanter J, Fullerton HJ, Debenham E, Brown L, et al. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019;94(12):1335–43.

Article  PubMed  Google Scholar 

Kwiatkowski JL, Zimmerman RA, Pollock AN, Seto W, Smith-Whitley K, Shults J, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146(3):300–5.

Article  PubMed  PubMed Central  Google Scholar 

Schatz J, Brown RT, Pascual JM, Hsu L, DeBaun MR. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology. 2001;56(8):1109–11.

Article  CAS  PubMed  Google Scholar 

Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014–8.

Article  CAS  PubMed  Google Scholar 

Rallo MS, Akel O, Kalakoti P, Sun H. Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome. J Stroke Cerebrovasc Dis. 2022;31(10): 106705.

Article  PubMed  Google Scholar 

Newman S, McMahon JT, Boulter JH, Malcolm JG, RevueltaBarbero JM, Chern JJ, et al. Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome. Neurosurgery. 2022;90(4):441–6.

Article  PubMed  Google Scholar 

Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia A randomized trial. N Engl J Med. 1986;314(25):1593–9.

Article  CAS  PubMed  Google Scholar 

World Health Organization. Fifty-ninth world health assembly 2006. https://apps.who.int/gb/ebwha/pdf_files/WHA59-REC1/e/WHA59_2006_REC1-en.pdf.

Muschick K, Fuqua T, Stoker-Postier C, Anderson AR. Real-world data on voxelotor to treat patients with sickle cell disease. Eur J Haematol. 2022;109(2):154–61.

Article  CAS  PubMed  Google Scholar 

Reeves SL, Madden B, Freed GL, Dombkowski KJ. Transcranial doppler screening among children and adolescents with sickle cell anemia. JAMA Pediatr. 2016;170(6):550–6.

Article  PubMed  PubMed Central  Google Scholar 

Venketasubramanian N, Prohovnik I, Hurlet A, Mohr JP, Piomelli S. Middle cerebral artery velocity changes during transfusion in sickle cell anemia. Stroke. 1994;25(11):2153–8.

Article  CAS  PubMed  Google Scholar 

DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020;4(8):1554–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reeves SL, Fullerton HJ, Cohn LM, Dombkowski KJ, Boulton ML, Braun TM, et al. Missed opportunities for transcranial doppler screening among children with sickle cell disease. Clin Pediatr (Phila). 2016;55(12):1093–9.

Article  PubMed  Google Scholar 

Reeves SL, Freed GL, Madden B, Wu M, Miller L, Cogan L, et al. Trends in quality of care among children with sickle cell anemia. Pediatr Blood Cancer. 2022;69(2): e29446.

Article  PubMed  Google Scholar 

Raphael JL, Shetty PB, Liu H, Mahoney DH, Mueller BU. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality. Pediatr Blood Cancer. 2008;51(5):647–51.

Article  PubMed  Google Scholar 

Reeves SL, Ng S, Dombkowski KJ, Raphael JL, Chua KP. TCD screening and spending among children with sickle cell anemia. Am J Manag Care. 2023;29(3):e79–84.

Article  PubMed  PubMed Central  Google Scholar 

Cabana MD, Kanter J, Marsh AM, Treadwell MJ, Rowland M, Stemmler P, et al. Barriers to pediatric sickle cell disease guideline recommendations. Glob Pediatr Health. 2019;6:2333794X19847026.